Search

everythinglearnresearchcommunity

for

Search:↓

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Mechanical stimulation and new therapies show promise for hair regrowth.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Finasteride may help some women with hair loss, but better options exist.

A rare pancreatic tumor caused a woman's male-like features, treated successfully with surgery and medication.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

Combining letrozole with metformin is the most effective treatment for inducing pregnancy in women with PCOS.

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

A rare ovarian tumor caused a postmenopausal woman to develop male-like features, which improved after surgery.

HST and HST/F promote hair growth and may help treat alopecia.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.